Expand GALT Menu
GALT MENU

Galectin Therapeutics (GALT) closed at $3.05 on November 13, 2026, down 2.9% from the previous close, on volume of 172,741 shares (30-day average 199,771).

Key numbers
  • Last close: $3.05 (November 13, 2026)
  • 52-week range: $2.03 to $7.13
  • Market value: $307.6 million
  • 30-day implied volatility (IV30): 100.1%
  • Option volume: 247 contracts (203 calls, 44 puts); 30-day average 213

Data as of November 13, 2026.

GALT Stock Summary and Trading Ideas (Galectin Therapeutics | NASDAQ:GALT)

Charts for Today's Stock Price and Implied Volatility in Galectin Therapeutics

13-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for GALT by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Oct 16, 2026 Calendar Call Spread 16-Oct : 20-Nov-26 5 C 210

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days

Trading Statistics

Key Ratios

Galectin Therapeutics (GALT) Frequently Asked Questions

What does Galectin Therapeutics do?

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

What symbol and exchange does Galectin Therapeutics shares trade?

Galectin Therapeutics trades on the NASDAQ stock market under the symbol GALT.

What is Galectin Therapeutics stock price doing today?

As of November 13, 2026, GALT stock price declined to $3.05 with 172,741 million shares trading.

What is Galectin Therapeutics's Beta?

GALT has a beta of -0.53, meaning it tends to be less sensitive to market movements. GALT has a correlation of 0.01 to the broad based SPY ETF.

How much is Galectin Therapeutics worth?

GALT has a market cap of $307.59 million. This is considered a Small Cap stock.

What is the highest and lowest price Galectin Therapeutics traded in the last 3 year period?

In the last 3 years, GALT traded as high as $7.13 and as low as $.73.

What are the top ETFs holding Galectin Therapeutics?

The top ETF exchange traded funds that GALT belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.

Is Galectin Therapeutics (GALT) a good investment?

GALT has underperformed the market in the last year with a price return of -44.8% while the SPY ETF gained +13.4%. GALT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -13.6% and -8.1%, respectively, while the SPY returned -2.8% and -0.2%, respectively.

What are the support and resistance levels for Galectin Therapeutics (GALT)?

GALT support price is $2.94 and resistance is $3.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GALT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes